DiscoverIPO

OPT

expected
Jun 26, 2026
status
Listed
proposed ticker
OPTS
Industry
Health Services
Headquarters
Italy
Exchange
EURONEXT
Underwriters
Integrae SIM

Overview

OPT S.p.A. specializes in consulting, training, and digital services in the public and private healthcare sectors. Net sales break down by activity as follows:definition and implementation of accreditable and certifiable governance models (73.6%);development of digital solutions and patient support programs (11.1%): designed to support care pathways (including online software for managing patients with psoriasis, cancer screening tools, and a web platform for monitoring and managing the nutritional status of cancer patients);organizing scientific events and accredited continuing education programs for healthcare professionals (11%);drafting medical content (4.3%): writing articles, clinical documents, and informational materials in accordance with applicable methodological standards and regulations.

From the company's own published profile, not AI-generated.

IPO details

OPT's offering is currently listed on Euronext Growth. The expected date is Jun 26, 2026. The proposed ticker is OPTS. Underwriters on the deal include Integrae SIM. OPT is headquartered in Italy. It is classified under Health Services.

Estimated post-listing dates

The dates below are calculated from widely-used industry conventions, not from this offering's own disclosed terms — DiscoverIPO does not have a structured source for the actual figures. Treat them as reference points, not confirmed dates.

  • Lock-up expiry (estimated): Dec 23, 2026, based on a customary 180-day lock-up period. The actual length is set in the underwriting agreement — typically 90 to 180 days — and this offering's real terms may differ.

Related IPO lists

Other IPOs DiscoverIPO tracks that share a sector, market, or underwriter with OPT.

Embed this company

Drop a live deal card into your own site — works in WordPress, Ghost, Notion, Webflow, and any self-hosted page that allows an <iframe>. It does not work in Substack or in an emailed newsletter — no email client, and Substack itself, supports arbitrary iframes. For those, use the share image or the attribution text below instead.

Iframe — WordPress / Ghost / Notion / Webflow

<iframe src="https://www.discoveripo.com/embed/opt" width="100%" height="300" style="border:0;max-width:560px" loading="lazy" title="OPT — DiscoverIPO"></iframe>

Dark by default. For a light background, use https://www.discoveripo.com/embed/opt?theme=light as the src instead.

Share image — Substack, email, anywhere

https://www.discoveripo.com/ipo/opt/opengraph-image

Attribution text

OPT IPO details — tracked by DiscoverIPO: https://www.discoveripo.com/ipo/opt?utm_source=embed&utm_medium=text&utm_campaign=opt

Track this IPO

Get emailed when OPT's terms, price, or expected date change — no weekly noise, just this company.

Frequently asked questions

When is OPT expected to go public?

OPT is expected to list on Jun 26, 2026.

What exchange will OPT list on?

OPT is listing on Euronext Growth.

What is OPT's ticker symbol?

OPT's proposed ticker is OPTS.

What does OPT do?

OPT S.p.A. specializes in consulting, training, and digital services in the public and private healthcare sectors. Net sales break down by activity as follows:definition and implementation of accreditable and certifiable governance models (73.6%);development of digital solutions and patient support programs (11.1%): designed to support care pathways (including online software for managing patients with psoriasis, cancer screening tools, and a web platform for monitoring and managing the nutritional status of cancer patients);organizing scientific events and accredited continuing education programs for healthcare professionals (11%);drafting medical content (4.3%): writing articles, clinical documents, and informational materials in accordance with applicable methodological standards and regulations.

Where this data comes from

Euronext's IPO showcase — a record of companies that have already listed, not an advance-notice feed. Retrieved Aug 3, 2026.

View the original filing on Euronext

Not investment advice. DiscoverIPO is an informational database. Nothing here is a recommendation to buy or sell any security, and no content should be relied on as financial advice. All figures come from public securities-regulator filings, may be incomplete or out of date, and should be verified against the original source before you act on them.

We use analytics and marketing cookies to understand traffic and improve the site. Cookie Policy